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ABSTRACT
Biliary atresia (BA) is a disease of the extrahepatic biliary tree that presents with biliary obstruction in the 
neonatal period, which is caused by  bro-obliterative process. Kasai procedure, a hepatoportoenterostomy 
(HPE) as an attempt to restore bile  ow from the liver to the proximal small bowel, has been shown to improve 
survival in BA patients. Many BA survivals who had undergone Kasai HPE will have slowly progressive liver 
disease and the majority of patients will ultimately require liver transplantation. In spite of many experimental 
treatments, cirrhosis still occurs in BA patients survival.
 This case report presents a male patient with biliary atresia that has survived for 27 years after Kasai 
procedure. He had been repeatedly admitted to hospital with complications caused by cirrhosis, such as repeated 
variceal and hemorrhoid bleeding and also refractory ascites. These complications are indications for liver 
transplantation. Although Kasai HPE procedure improves survival in BA patients in Indonesia, long-term 
complications of cirrhosis makes the patient awaits for liver transplantation. 
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ABSTRAK
Atresia bilier (AB) adalah penyakit pada saluran bilier ekstrahepatik yang menimbulkan sumbatan bilier pada 
periode neonatal disebabkan proses  bro-obliterasi. Prosedur Kasai merupakan suatu hepatoportoenterostomi 
(HPE) adalah tindakan untuk mengalihkan aliran empedu dari hati ke usus kecil, telah meningkatkan kesintasan 
pasien AB. Kebanyakan pasien AB yang selamat setelah menjalani Kasai HPE akan menderita penyakit hati 
yang progresif dan akhirnya mayoritas pasien akan membutuhkan transplantasi hati. Walaupun terdapat banyak 
terapi yang telah dicoba diberikan, sirosis tetap terjadi pada pasien AB yang selamat. 
Kasus ini melaporkan pasien laki-laki dengan atresia bilier yang dapat bertahan sampai 27 tahun setelah 
menjalani prosedur Kasai dan mendapat perawatan berulang kali karena komplikasi sirosis seperti perdarahan 
varises dan hemoroid serta refraksi asites. Komplikasi yang terjadi merupakan indikasi dari transplantasi hati. 
Walaupun prosedur Kasai HPE dapat meningkatkan kesintasan pasien AB di Indonesia, komplikasi jangka 
panjang seperti sirosis masih memerlukan penatalaksanaan lanjutan yaitu transplantasi hati. 
Kata kunci: atresia bilier, prosedur Kasai, hepatoportoenterostomi, sirosis, transplantasi hati
INTRODUCTION
Biliary atresia (BA) is a progressive, idiopathic, 
 bro-obliterative disease of the extrahepatic biliary 
tree that presents with biliary obstruction exclusively 
in the neonatal period. The overall incidence of BA 
is low, i.e. about one in 10,000 to 20,000 live births. 
The incidence of BA varies from 5/100,000 live births 
in The Netherlands, 6/100,000 in the British Isles, 
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6.5/100,000 in Texas, 7.4/100,000 in Atlanta USA and 
in Japan, 10.6/100,000 in Hawaii, up to 32/100,000 in 
French Polynesia. Incidence of BA reaches the highest 
in Asia and the Paci c region.1 
After diagnosis of BA is con rmed by cholangiogram, 
a Kasai procedure which is a hepatoportoenterostomy 
(HPE) should be performed promptly. The procedure 
is an attempt to restore bile  ow from liver to proximal 
small bowel. Despite the bile  ow is established after 
Kasai procedure and cholestasis is improved, many 
patients will have slowly progressive liver disease 
and the majority of patients will ultimately require 
liver transplantation.2,3 Although the performance of 
Kasai HPE clearly improves survival overall, but the 
long-term prognosis is dif cult to predict. Half of the 
20-year survivors had cirrhosis and 20% underwent 
liver transplant or experienced death within a few 
years of period.
Improvements in medical therapy after Kasai HPE, 
such as prophylaxis against cholangitis, improvements 
in nutrition, bile flow, and experimental therapy 
such as anti-fibrotic or anti-inflammatory agents 
may increase survival of BA patients in the future. 
This case report will discuss a male patient with 
biliary atresia that has survived for 27 years after 
Kasai procedure. He has been repeatedly admitted to 
hospital with complications caused by cirrhosis. These 
complications need immediate management, including 
liver transplant. In spite of improving survival rate of 
BA patients in Kasai procedure, further evaluation 
and management must be performed to minimize 
complications. 
CASE ILLUSTRATION
A 27-year-old male patient was admitted to 
emergency room of Cipto Mangunkusumo Hospital 
with a chief complaint of altered consciousness one day 
before admission. Two weeks prior to the admission, he 
experienced bloody stool and underwent colonoscopy 
revealing internal and external hemorrhoid, which 
was treated further with sclerotherapy and he also 
had complaints of vomiting and abdominal pain since 
3 days before the admission. He had brown-colored 
stool with no blood nor acholic, urine was dark colored. 
He has never experienced fever, cough, dyspnea or 
palpitation. 
When patient was two months old, he was 
diagnosed with biliary atresia and underwent Kasai 
procedure for repair of cholestasis in Harapan Kita 
Women and Children Hospital. After a successful 
Kasai procedure, the dark-colored urine and acholic 
stool were improved. He had routine visits to Harapan 
Kita Women and Children Hospital and  nally had 
no more complaints until he was 17-years old. At 17 
years of age, his complaints of dark-colored urine 
and acholic stool recurred and he was diagnosed with 
biliary cirrhosis. The complaints of coffee-ground 
stool and vomiting appeared for  rst time when he 
was 21-years old and since then, patient had undergone 
esophagogastroduodenoscopy and ligation for grade III 
esophageal varices for 4 times. Patient was admitted 
to hospital for 11 days and was discharged home on 
treatment of omeprazole, sucralfate,curcumin and 
spironolactone. 
The physical examination revealed normal vital 
signs. The patient was awake and fully-alert. The 
conjunctivas of his eyes were anemic and the sclera was 
jaundiced. His liver was enlarged in the size of 4  ngers 
below the costal arch with blunt edge. Spelneomegaly 
was found (Schuffner II), but no shifting dullness was 
found and clubbing  ngers were noticed, which are 
illustrated in Figure 1.
Ultrasound (US) examination, which was performed 
on January 1st, 2012, showed decreased in the size of 
the left hepatic lobe with irregular border, widened 
portal vein, increased echogenicity of intra and 
extrahepatic biliary tract as well as lienalis artery. It was 
dif cult to evaluate the common bile duct. (Figure 2). 
Two weeks later,  the patient  underwent 
esophagoduodenoscopy which revealed grade III 
esophageal varices and severe portal hypertensive 
gastropathy. Afterward, in one month, the results 
of colonoscopy examination showed small external 
hemorrhoid, large grade II internal hemorrhoid, 
Figure 1. Physical  ndings showed ascites and clubbing  ngers
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Figure 2. Abdominal ultrasonography of the patient showed 
decrease in the size of the left hepatic lobe with irregular bor-
der, widened portal vein, increased echogenicity of intra and 
extrahepatic biliary tract as well as lienalis artery. It was dif cult 
to evaluate the common bile duct
Figure 3. Esophagoscopy and colonoscopy showed small 
external hemorrhoid, large grade II internal hemorrhoid, 
colonopathy, enteropathy, and no active bleeding
DISCUSSION
Biliary atresia (BA) is a progressive, idiopathic, 
 bro-obliterative disease of the extrahepatic biliary 
tree that presents with biliary obstruction and occurs 
exclusively in the neonatal period. BA is the most 
common cause of neonatal jaundice for which 
surgery is indicated and also as indication for liver 
transplantation in children.1 
Infants with BA can be categorized into three groups: 
(1) BA without any other anomalies or malformations. 
This pattern is sometimes known as perinatal BA 
that occurs in approximately 70% of infants with 
BA. Typically, these children are born jaundice-free, 
within the  rst two months of life, jaundice develops 
and stools become progressively acholic; (2) BA in 
association with laterality malformations, which is also 
known as biliary atresia splenic malformation (BASM) 
or embryonic biliary atresia. It occurs in 10 to 15% 
of infants with BA; (3) BA in association with other 
congenital malformations that occurs in the remaining 
10-15% of BA cases. It is associated with congenital 
malformations including choledochal cyst, kidney 
anomalies, and/or heart malformations.2-5 Regardless 
of the type of BA, the histology and cholangiogram 
are similar. Histologic findings typically show 
in ammation, portal tract  brosis, cholestasis, and bile 
duct proliferation; while the cholangiogram indicates 
loss of patency of the bile ducts. 
The cause of BA is unknown, although several 
mechanisms have been implicated. In some patients, 
several of these mechanisms may contribute to the 
development of BA. In others, BA may be the common 
phenotype that can be caused by a variety of injuries 
to the biliary system occurring in the perinatal period. 
Studies suggest a possible viral etiology, also with the 
possibility of a toxin-mediated in ammatory response. 
Until today, neither speci c virus nor toxin has been 
implicated in the development of BA in both animals and 
human subjects. Genetic factors may play a causative 
colonopathy, enteropathy, and no active bleeding 
(Figure 3.). Further laboratory evaluation revealed 
hemoglobin level of 10.3 g/dL, leukocytes count 
of 8,370/mL and platelet count of 58,800/mL. His 
prolonged activated partial thromboplastin time 
(APTT) was 52.7 seconds (normal limit of 32.6 
seconds), and the prothombin time (PT) was 17.4 s 
(normal limit of 11.8 s). The aspartate transaminase 
(AST) and alanine aminotransferase (ALT) level were 
increased to 353 IU/L and 101 IU/L. The patient had 
hypoalbuminemia with albumin level of 2.4 g/dL and 
the bilirubin levels were increased too with total, direct, 
and indirect were 38.77 mg/dL, 25.18 mg/dL, 13.59 
mg/dL, respectively. 
The patient’s problems were biliary cirrhosis with 
history of hepatic encephalopathy, thrombocytopenia 
and coagulopathy, grade III esophageal varices, internal 
and external hemorrhoid, biliary atresia with history of 
Kasai Procedure in infancy period. Patient was treated 
with L-ornithin L-aspartate, propranolol, furosemide 
and spironolactone, vitamin K, ceftazidime and 
levo oxacine during hospitalization. Patient received 
fresh frozen plasma transfusion for the correction of 
coagulopathy. After having a ligation procedure of 
esophageal varices, the patient was discharged home. 
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role in the small subgroup of patients with BASM 
malformations, such mutations in the CFC1 gene.2-4 
The evaluation process involves a series of 
serologic, laboratory, urine, and imaging tests. If BA 
is con rmed by cholangiogram, a Kasai procedure of 
hepatoporto-enterostomy (HPE) should be performed. 
If successful, the remaining small patent bile ducts 
will drain into the roux limb and jaundice will start to 
resolve in the weeks following surgery. If unsuccessful, 
bile drainage will not be achieved, and the child 
remains jaundiced. If there is persistent jaundice three 
months after the Kasai, the patient should be referred 
for liver transplant evaluation. Revision of a non-
functioning HPE is not recommended except in rare 
circumstances.1-3 
Even if bile  ow is established and cholestasis 
improves, many patients will have slowly progressive 
liver disease despite undergoing the Kasai procedure, 
and the majority of patients with BA will ultimately 
require liver transplantation. At least 50% of patients 
who undergo HPE will require liver transplantation by 
two years of age as a result of primary failure of the 
Kasai HPE and/or growth failure. The patient’s age at 
the time of HPE can predict native liver survival at later 
time points. For patients who undergo HPE ≤ 30 days 
of life, the chance of native liver survival at four years 
of age is nearly 50%; while among those who undergo 
HPE between 31 and 90 days of life, the chance of 
native liver survival at four years of age is 36%.6-8
The Kasai HPE obviates the need for liver 
transplantation in a substantial minority and signi cantly 
delays the liver transplantation for many others. If bile 
drainage is achieved, it is likely that transplantation 
will not be needed for years or decades. Historical 
series before the Kasai procedure was introduced in 
1968 report a 10% survival rate at three years of age, 
as compared with the 35 to 50% survival rates with 
native liver at four years of age. Medical care following 
Kasai HPE consists of the following interventions, i.e. 
the choleretics and possible use of anti-in ammatory 
medications, nutritional rehabilitation, fat-soluble 
vitamin supplementation, prevention of cholangitis, 
and management of portal hypertension and its 
sequelae.9,10
Cholangitis is a common complication in patients with 
BA who have undergone a Kasai HPE ranging between 
40 and 90%, with the majority of patients experiencing at 
least one episode prior to two years of age. The chronic 
hepatobiliary in ammation characteristic of BA leads 
to progressive biliary cirrhosis.9-11 
The majority of individuals with BA eventually 
require liver transplantation, where BA is the 
most common indication for liver transplantation 
in infants and children. In the current era, at least 
60 to 80% of patients with BA will require liver 
transplantation, even with optimal management. The 
indications for liver transplantation in patients with 
BA include primary failure of the Kasai HPE or lack 
of bile drainage, refractory growth failure in spite 
of adequate supplemental nasogastric tube feeding, 
complications of portal hypertension, repeated 
variceal bleeding, refractory ascites that compromises 
respiratory function, hepatopulmonary syndrome, 
portopulmonary hypertension, progressive liver 
dysfunction, progressive cholestasis, and refractory 
coagulopathy.
For those children who require liver transplantation, 
the prognosis is generally good. In international series, 
long-term survival rates are approximately 70 to 80% at 
both 5 and 10 years and these rates continue to improve 
as demonstrated in more recent case series. The liver 
transplant surgery in BA patients is complicated by 
the presence of intra-abdominal adhesions attributed 
to previous HPE. 
Long term prognosis for BA patients is still variable, 
but complementary approaches of HPE and liver 
transplantation improve long-term survival with up to 
90% of BA patients survived into adulthood. Overall 
survival rate with native liver ranges from 30-55% 
at 5 years and 30-40% at 10 years.9 One study with 
long-term follow-up included 271 patients who 
underwent the procedure between 1968 and 1983 
found that 63 patients (23%) were alive with native 
liver for at least 20 years after surgery. The majority 
of survivors (61 patients) had evidence of chronic liver 
disease or cirrhosis. Most required lifelong care for 
management of hepatobiliary complications.10 Latest 
series reported 5-, 10-, and 20-year survival rates with 
native livers of 63%, 54%, and 44%, respectively. 
Half of the 20-year survivors had cirrhosis, and 20 
% went on to liver transplant or death within a few 
years.11 Experimental therapy such as anti- brotic 
or anti-in ammatory agents may improve outcomes 
in the future. Because biliary atresia is not restricted 
to the extrahepatic bile duct, patients with successful 
HPE display abnormalities of the intrahepatic biliary 
tree, including stenosis, dilatation, and sometimes 
pseudocyst formation. Intrahepatic change could lead 
to hepatic cirrhosis and affect portal hypertension.11,12
This case reported a 27-year-old male patient is 
an example of successful Kasai HPE, which had been 
performed to BA patient in the neonatal period. It 
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also shows the predicted outcome of that successful 
procedure, i.e. the biliary cirrhosis along with its 
complications due to portal hypertension. Furthermore, 
the case also reminds us about the need of liver 
transplantations in BA patients after Kasai HPE, which 
should be taken into consideration in the follow up of 
BA survivals.
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